Etienne-Emile Beaulieu is a French biologist, doctor of medicine (1955) and doctor of sciences (1963). He was director of a research unit at INSERM and professor of biochemistry at the University of Paris-Sud. He is professor emeritus at the Collège de France and was notably president of the French Academy of Sciences in 2003 and 2004. A specialist in steroid hormones, he is known worldwide for the development of the anti-progesterone RU 486 (or abortion pill). He also founded the Baulieu Institute in June 2008, to support its research against Alzheimer's disease and depression. Etienne-Emile Beaulieu was elected member of the Academy of Sciences on February 8, 1982 and chaired it in 2003-2004. Professor emeritus at the Collège de France, from 1996 to 2004 he was a member of the National Consultative Ethics Committee for life and health sciences. He has been a member of the Academy of Medicine since 2002. He has also been a member of the American National Academy of Sciences since 1990. He has received several prizes and distinctions in France, such as the INSERM honorary prize in 2015, and abroad, such as the Albert-Lasker prize in 1989.

Ludger Johannes has specialized in the field of endocytosis and intracellular trafficking. He and his team study how sugars attached to proteins or lipids influence the transport of biological material into eukaryotic cells. Johannes is research director “classe exceptionnelle”(DRE) at the Institut Nationale de la Santé et de la Recherche Médicale (INSERM, where he was recruited in 1997. He currently directs the Cellular and Chemical Biology department (U1143 INSERM–UMR3666 CNRS) at Institut Curie in Paris, France. He is an elected member of the European Molecular Biology Organization (EMBO], and German Academy of Sciences Leopoldina and an alumnus of the Germany-based Boehringer Ingelheim Fond–Foundation for Basic Research in Medicine and the German Academic Scholarship Foundation Studienstiftung des deutschen Volkes.

Dr. Jiong Wu, distinguished professor of School of Life Sciences, Jiangsu Normal University, was officially granted the honor of becoming Foreign Academician of the Russian Academy of Engineering (RAE) on April 20, 2022, in recognition of his outstanding achievementsin immunotherapy programs of tumor cells. Prof. Jiong Wu is a core scientistof the key biotechnology lab on medicinal and edible plants of Life Sciences, Jiangsu Normal University, has committed himself to the study of basic theory and clinical treatment of tumor immunology as well as the R&D of related products for a long time.  He has won many prizes including Ferid Murad Prizefrom ISICR.

Dr. Ye-Lehmann graduated from the Chemistry Department of Peking University with a bachelor degree. She went to the USA in 1998 and received PhD in chemistry from the University of Pennsylvania in 2004. She moved to France as a research fellow at the Institute of Biology of Ecole Normale Superieure (ENS) in 2010, sponsored by the Pierre-Gille de Gennes Foundation. She subsequently became a project leader in ENS and was recruited by INSERM as a tenured researcher in 2011. In 2016, through an open call competition, she was awarded to set up a Synthetic Biology Team in the Laboratory of Computational and Quantitative Biology of the Sorbonne University. From 2016 to 2019, she moved to the INSERM U1195 unit specialized in neurosteroids and diseases, which situated inside the Bicetre Hospital. Since then she focuses on innovative optogenetics tools to study structural-function relationships of neuronal receptors, and providing therapeutic insights for anesthesia and diseases such as the Alzheimer's. She has published more than 50 papers in journals.

Zefeng Wang, Distinguished Professor and Doctoral Supervisor of Huzhou University, Director of the Institute of Perception and Control Technology, College of Information Engineering, Huzhou University. He successively obtained a Bachelor's degree in applied Physics, a Master's degree in mechanical and Systems Engineering, and a Doctor's degree in mechanics, electronics, acoustics and robotics from Université Paris VI. After that, he served as an Associate Professor at the Catholic University of Paris. He moved to China in 2017 as a Distinguished Professor and concurrently served as a Guest Professor at JUNIA Grande école d'ingénieurs. At the end of 2020, he joined Huzhou University as a Distinguished Professor and jointly trained doctoral students with Sorbonne University and Lille University.

Changting Li is a highly experienced cell biologist with a specialization in immunology, boasting a decade of dedicated expertise in lipid-related preclinical drug development. Profound knowledge in specific lipid-controlled receptor signaling activation, with a remarkable track record of accomplishments. He has analysed the role of specific lipids in T-cell activation, persistence of JAK-STAT signaling (Cytokines) and PDL1 degradation, resulting in three key publications as the first author featured in prestigious journals (Nature Communications, PNAS and etc.) and two presentations at international lipid conferences.